Charu Aggarwal: Thoroughly impressed with ASCO TECAG programming this year!
Charu Aggarwal shared a post by Fernando Diaz, Geriatric-Oncology Fellow at University of North Carolina, on X, adding:
“Thoroughly impressed with ASCO TECAG programming this year! Kudos to ASCO 24 and the planning committees. It wouldn’t be possible without Mandy Davis Aitken- she is a magician! Fernando Diaz, Ramy Sedhom, Ana I. Velázquez Mañana, Aakash Desai.”
Quoting Fernando Diaz’s post:
“I want thank Mandy Davis Aitken, ASCO VP of Meeting Services, who met with the ASCO TECAG during the initial planning of the new ASCO24 TECLounge and incorporated all of our feedback. She is diligent, hardworking, and an expert in her field. Thank you, Mandy.”
Source: Charu Aggarwal/X and Fernando Diaz/X
Charu Aggarwal, MD, MPH, is an Associate Director and Innovation Faculty member at the Penn Center for Cancer Care Innovation (PC3I) and Director of the Program in Precision Oncology Innovation at PC3I. She holds the title of Leslye Heisler Associate Professor of Medicine at the University of Pennsylvania’s Perelman School of Medicine.
Dr. Aggarwal is a leading expert in lung cancer management, focusing on novel immunotherapeutic approaches and biomarker-guided therapies. She spearheads multiple clinical trials, including those involving cellular therapy and CAR-T for solid tumors.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023